SCHEMBL13243797

SCHEMBL13243797

Cc1cc(-c2ccc(N=Nc3c(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(N)c4c3O)c(C)c2)ccc1N=Nc1c(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(C)c2c1O

nearest known ligand 0.94

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.94
▸ KMT2A Q03164 2/20 0.94
▸ HTT P42858 1/20 0.94
▸ PHLPP2 Q6ZVD8 2/20 0.78
▸ ENPP2 Q13822 9/20 0.72
▸ PTPN1 P18031 2/20 0.71
▸ USP2 O75604 1/20 0.71
▸ ATM Q13315 1/20 0.71
▸ L3MBTL1 Q9Y468 1/20 0.71
▸ CYP1A2 P05177 2/20 0.57
▸ SUMO2 P61956 1/20 0.56
▸ SUMO1 P63165 1/20 0.56
▸ SENP7 Q9BQF6 1/20 0.56
▸ SENP3 Q9H4L4 1/20 0.56
▸ SENP2 Q9HC62 1/20 0.56
▸ SENP1 Q9P0U3 1/20 0.56
▸ PRMT1 Q99873 1/20 0.53
▸ ALDH1A1 P00352 2/20 0.51
▸ CYP2C9 P11712 2/20 0.51
▸ MAPK1 P28482 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trypan Blue Free Acid SCHEMBL29415031 0.97 MEN1 (1.00) MEN1KMT2AHTTPHLPP2ENPP2
Trypan Blue Free Acid SCHEMBL29355441 0.97 MEN1 (1.00) MEN1KMT2AHTTPHLPP2ENPP2
Trypan Blue Free Acid SCHEMBL29376676 0.97 MEN1 (1.00) MEN1KMT2AHTTPHLPP2ENPP2
Trypan Blue Free Acid SCHEMBL12234090 0.97 MEN1 (1.00) MEN1KMT2AHTTPHLPP2ENPP2
Trypan Blue Free Acid SCHEMBL15497820 0.97 MEN1 (1.00) MEN1KMT2AHTTPHLPP2ENPP2
SCHEMBL14664307 0.92 MEN1 (0.79) MEN1KMT2AHTTPHLPP2ENPP2
SCHEMBL24438814 0.91 MEN1 (0.87) MEN1KMT2AHTTPHLPP2ENPP2
SCHEMBL18784959 0.90 MEN1 (0.85) MEN1KMT2AHTTPHLPP2ENPP2
SCHEMBL21105389 0.90 MEN1 (0.85) MEN1KMT2AHTTPHLPP2ENPP2
SCHEMBL14215680 0.90 MEN1 (0.85) MEN1KMT2AHTTPHLPP2ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763442-B2 Method for detecting candida on skin KIMBERLY-CLARK WORLDWIDE, INC. (US) 2010-07-27 — — US disclosed
US-7531319-B2 Array for rapid detection of a microorganism KIMBERLY-CLARK WORLDWIDE, INC. (US) 2009-05-12 — — US disclosed
US-20080145316-A1 Skin coating with microbial indicator KIMBERLY-CLARK WORLDWIDE, INC. 2008-06-19 — — US disclosed
US-20080057533-A1 Array for rapid detection of a microorganism KIMBERLY-CLARK WORLDWIDE, INC. 2008-03-06 — — US disclosed
US-20080057532-A1 Method for detecting Candida on skin KIMBERLY-CLARK WORLDWIDE, INC. 2008-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080145316-A1 Skin coating with microbial indicator CUTA, S100A8, STING1 MEN1 1425/4885KMT2A 4538/4885HTT 3786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback